Bank Pictet & Cie (Asia) LTD Gilead Sciences, Inc. Transaction History

Bank Pictet & Cie (Asia) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 30, 2020	SELL	$62.63 - $80.22 $785,004 - $1.01 Million	-12,534 Closed	0 $0
Q4 2018 Jan 31, 2019	SELL	$60.54 - $79.0 $181,620 - $237,000	-3,000 Reduced 19.31%	12,534 $784,000
Q3 2018 Nov 07, 2018	SELL	$71.28 - $78.92 $169,646 - $187,829	-2,380 Reduced 13.29%	15,534 $1.2 Million
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $901,442 - $1.05 Million	13,894 Added 345.62%	17,914 $1.27 Million
Q2 2017 Aug 09, 2017	BUY	N/A	4,020	4,020 $285,000

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Bank Pictet & Cie (Asia) LTD, based on Form 13F filings with the SEC.

Stay updated on Bank Pictet & Cie (Asia) LTD with notifications on news.